EI
PMD

EAM Investors’s Psychemedics Corporation PMD Stock Holding History

EAM Investors’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-55,971
Closed -$1.38M – 379
2016
Q4 		$1.38M Sell
55,971
-1,604
-3% -$36K 0.18% 230
2016
Q3 		$1.14M Buy
+57,575
New +$1.07M 0.15% 237

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

EAM Investors's PMD Position: Q1 2017 in Review

EAM Investors sold out of Psychemedics Corporation (PMD) in Q1 2017, closing a stake of 55,971 shares — an estimated $1.38M sold.

EAM Investors first reported a position in PMD in Q3 2016 and held it in 2 quarters. The position peaked at $1.38M in Q4 2016. 53 funds tracked by Wall St. Rank hold PMD as of Q1 2017.

  • EAM Investors reported no remaining Psychemedics Corporation position as of Q1 2017 after selling out during the quarter.
  • EAM Investors sold 55,971 Psychemedics Corporation shares in Q1 2017, an estimated $1.38M.
  • EAM Investors first reported a position in Psychemedics Corporation in Q3 2016 and held it in 2 quarters.
  • EAM Investors's Psychemedics Corporation position peaked at $1.38M in Q4 2016.
  • 53 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2017.

Based on EAM Investors's 13F filing for Q1 2017, filed 10 May 2017.